vimarsana.com

Page 18 - துலேன் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lyme bacteria survive antibiotics, even months later

The bacteria that cause Lyme disease can survive in organ tissue after treatment with a full course of antibiotics months after infection, according to a new study with non-human primates. The study results seem to support claims of lingering symptoms some patients who have received antibiotic treatment for the disease have reported. Researchers at Tulane National Primate Research Center studied 10 primates exposed to ticks carrying Borrelia burgdorferi, the bacteria that cause Lyme disease. Four months after infection, half of the animals received the antibiotic doxycycline orally for 28 days at a proportional dose to that used in human patients. Five animal subjects remained untreated and all were evaluated by more than five different diagnostic methods to characterize any remaining infection. Researchers used several important techniques, including xenodiagnoses, to determine if the bacteria persisted.

NanoPin Technologies Founder s Study Demonstrates Greater Accuracy in Detecting TB in Infants

NanoPin Technologies Founder s Study Demonstrates Greater Accuracy in Detecting TB in Infants Advanced diagnostics designed to mitigate the enduring TB epidemic Accurate detection platform has applications for COVID-19, HIV, and other infectious diseases News provided by Share this article Share this article NEW ORLEANS, May 19, 2021 /PRNewswire/  NanoPin Technologies Inc, a biotechnology company focused on developing advanced diagnostics to improve the lives of millions of individuals affected by infectious diseases worldwide, announced the release of a scientific study conducted by founder Tony Hu, Ph.D. Dr. Hu is  a professor and Weatherhead Presidential Chair in Biotechnology Innovation at the Tulane University School of Medicine. 

Children s Hospital Appoints Nobel Nominee

Biz New Orleans 05/17/2021 NEW ORLEANS – In July, Dr. Mark Kline will assume the role of physician-in-chief at Children’s Hospital New Orleans. “Dr. Kline’s expert leadership, together with the excellent pedigree of our academic partners, will allow Children’s to innovate care delivery while training our next generation of pediatricians,” said John R. Nickens IV, Children’s Hospital president and CEO, in a press release. “Over the last several years, Children’s has recruited administrative and physician leaders trained in some of the top pediatric programs across the country to join our mission. Combining the new perspectives of these extraordinary leaders with the strong, energized collection of LSU and Tulane pediatric experts has created a dynamic and distinct group of professionals ready to tackle the health challenges our kids and communities are facing.”

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.